Gilead's Adjusted First-Quarter Profit Beats Estimates

Thursday, 25 April 2024, 20:28

Gilead Sciences Inc. pleasantly surprised investors with better than expected performance in the first quarter. The drug company's adjusted profit margin narrowed, leading to a 0.8% rise in stock price during after-hours trading. This indicates a strong start to the year for Gilead amidst market uncertainties.
https://store.livarava.com/9daae687-0342-11ef-a6c0-63e1980711b2.jpg
Gilead's Adjusted First-Quarter Profit Beats Estimates

Gilead Sciences Inc. Performance

Gilead Sciences Inc.’s stock rose 0.8% in after-hours trading Thursday, after the drug company’s adjusted first-quarter profit was narrower than expected.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Do you want to advertise here?

Related posts


Do you want to advertise here?
Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe